JAK2 and essential thrombocythemia: The allelic frequency of the JAK2-V617F mutation in DNA and the expression levels of the mutant and wild-type JAK2 mRNA were determined in the granulocytes from 60 patients with ET and 62 patients with PV at the time of diagnosis.